Viewing StudyNCT00012324



Ignite Creation Date: 2024-05-05 @ 11:23 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00012324
Status: COMPLETED
Last Update Posted: 2013-06-26
First Post: 2001-03-03

Brief Title: Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer
Sponsor: Eximias Pharmaceutical
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Liver Cancer
Keywords:
Name View
localized unresectable adult primary liver cancer View
advanced adult primary liver cancer View
recurrent adult primary liver cancer View
adult primary hepatocellular carcinoma View